1-1 of 1
Louis Brenner, MD MBA
Close
Sort by
Journal Articles

IMO-8400, an Antagonist of Toll-like Receptors 7, 8, and 9, in Development for Genetically Defined B-Cell Lymphomas: Safety and Activity in Phase 1 and Phase 2 Clinical Trials

Louis Brenner, MD MBA, Robert D. Arbeit, MD, Tim Sullivan, PhD
Journal: Blood
Blood (2014) 124 (21): 3101.
https://doi.org/10.1182/blood.V124.21.3101.3101
Published: 2014